Cyclerion Therapeutics (CYCN) EPS (Diluted) (2021 - 2025)
Powered by 
Analysis
Cyclerion Therapeutics (CYCN) EPS (Diluted) (2021 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.95 Bn | 195.96 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 180.35 Bn | 177.17 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.26 Bn | 124.41 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.62 Bn | 74.62 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 61.19 Bn | 56.00 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.75 Bn | 30.44 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.58 Bn | 30.30 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.42 Bn | 29.42 Bn | 1.16 Mn | -0.40 |
| 10 | Cyclerion Therapeutics | 15.70 Mn | 12.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.54 |
| Mar 31, 2025 | -0.57 |
| Dec 31, 2024 | 0.20 |
| Sep 30, 2024 | -0.45 |
| Jun 30, 2024 | -0.55 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -0.77 |
| Sep 30, 2023 | 2.68 |
| Jun 30, 2023 | -1.86 |
| Mar 31, 2023 | -3.24 |
| Dec 31, 2022 | -3.38 |
| Sep 30, 2022 | -4.88 |
| Jun 30, 2022 | -6.18 |
| Mar 31, 2022 | -5.98 |
| Dec 31, 2021 | -7.33 |
| Sep 30, 2021 | -5.21 |
| Jun 30, 2021 | -9.06 |